Key stats
About NEUROGENESIS
NeuroGenesis, Inc. manufactures and markets nutritional supplements of a particular type. Its products are designed to increase the health of people suffering from a variety of mental and physical health disorders, such as hyperactivity, effects of anxiety and reactions to stressful situations, addictions and other physical disorders. The company was founded on November 13, 1984 and is headquartered in League City, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NEUN is 0.000100 USD — it hasn't changed in the past 24 hours. Watch NEUROGENESIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NEUROGENESIS stocks are traded under the ticker NEUN.
NEUN reached its all-time high on Jun 29, 2005 with the price of 0.550000 USD, and its all-time low was 0.000001 USD and was reached on Apr 12, 2022. View more price dynamics on NEUN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NEUN stock is 0% volatile and has beta coefficient of 5.43. Track NEUROGENESIS stock price on the chart and check out the list of the most volatile stocks — is NEUROGENESIS there?
No, NEUN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NEUN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROGENESIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEUROGENESIS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEUROGENESIS stock shows the sell signal. See more of NEUROGENESIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.